#VU63963 Improper access control in Illumina products - CVE-2022-1521

Vulnerability identifier: #VU63963

Vulnerability risk: High

CVSSv4.0: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/U:Amber

CVE-ID: CVE-2022-1521

CWE-ID: CWE-284

Exploitation vector: Remote access

Exploit availability: No public exploit available

Vulnerable software:
In Vitro Diagnostic NextSeq 550Dx
In Vitro Diagnostic MiSeq Dx
NextSeq 500 Instrument
NextSeq 550 Instrument
MiSeq Instrument
iSeq 100 Instrument
MiniSeq Instrument
Local Run Manager (LRM)

Software vendor:
Illumina

The vulnerability allows a remote attacker to gain unauthorized access to otherwise restricted functionality.

The vulnerability exists due to improper access restrictions. A remote attacker can bypass implemented security restrictions and inject, replay, modify, and/or intercept sensitive data.

Install updates from vendor's website.

• https://ics-cert.us-cert.gov/advisories/icsa-22-153-02